Deflectable catheters are used for minimally invasive procedures such as coronary interventions and electrophysiology applications. Due to the upgradation of technology, the core tip can deflect at a certain angle. According to the latest research by FMI, the global deflectable catheters market is expected to account for more than US$ 2,400.0 Mn in terms of value by the end of 2029. The deflectable catheters market report also projects a significant growth potential in the market with a CAGR of ~ 4% during the forecast period.
Companies Eyeing Untapped Opportunities in Cost-sensitive Regional Markets
The current adoption pattern among healthcare professionals favour the use of reposable medical devices, a trend that is most certainly observed in developing countries, to complement the cost factor and availability. In contrast, most of the deflectable catheters used are one-time use products. Factors like blood, debris prevent using reposable deflectable catheters in operations as critical as electrophysiology.
Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5852
The usage of reposable deflectable catheters is significantly higher in developing economies with inadequate resources, where the cost of treatment can be significantly high, which is unfavourable for patients from poor backgrounds. The present cost structure with the use of reposable deflectable catheters makes it feasible for a sizeable population to opt for low-cost treatment options, which help boost the adoption rate, and thereby expand the consumer pool.
At present, there are only a few companies offering reposable deflectable catheters, and none of the major players are into developing reposable devices. As per the report, a comparatively smaller company, CathRx, has a similar reposable product, Khelix, which is considered to be the first ‘reposable’ diagnostic and therapeutic catheter for the treatment of cardiac arrhythmias.
Download Segment-wise Analysis@ https://www.futuremarketinsights.com/checkout/5852
Acquisitions & Collaborations Playing Decisive Role in Shaping Deflectable Catheters Market Structure
The affective adjustments and development observed in the parent market influences the deflectable catheters market. The recent trend of involving digital methods for diagnosing cardiac problems is also changing the treatment pattern. All these trends are more governed by the top market leaders in the cardiology market. With abundant resources and investment plans, they manipulate the industry in a way in which no other smaller or regional manufacturer is capable of keeping pace with them.
The trend of acquisition and forming a strategic partnership is positive delivering financial results. For example, Abbott’s acquisition of St. Jude Medical resulted in the consolidation of the 2nd and 4th largest cardiology market players. Moreover, the acquisition of specific treatment technologies has also been observed in the deflectable catheter market, and there has been an increase in the number of players expanding their product portfolio for the treatment of atrial fibrillation/atrial flutter.
Download Data Set @ https://www.futuremarketinsights.com/askus/rep-gb-5852
Deflectable Catheters Market: Segmental Analysis
On the basis of product type, the deflectable catheters market has been segmented into uni-directional deflectable catheters, bi-directional deflectable catheters, and multi-directional deflectable catheters. Bi-directional deflectable catheters lead the market due to their high adoption rate and availability.
Based on application, the deflectable catheters market has been segmented into coronary interventions, electrophysiology, diagnostics imaging, and peripheral interventions. In terms of revenue, the electrophysiology segment is expected to have a major share in the deflectable catheters market due to an increase in the number of procedures being carried out by deflectable catheters.
On the basis of end user, the deflectable catheters market has been categorised into hospitals, office-based clinics, ambulatory surgical centres, and independent catheterisation labs. Independent catheterisation labs are expected to witness significant growth, which is driven by an increase in the number of the same.
Some of the key players in the deflectable catheters market include Medtronic Plc, Merit Medical Systems, JOHNSON & JOHNSON, Teleflex Incorporated, Boston Scientific Corporation, Biomerics LLC, OSYPKA AG, Abbott, Japan Lifeline Co., CathRx Ltd., and Biotronik SE & Co. KG.